UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab-Challenging Recognition and Treatment

Viruses, 2023-03, Vol.15 (3), p.693

2023

Volltextzugriff (PDF)

Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

European heart journal, 2014-09, Vol.35 (34), p.2279-2284

2014

Volltextzugriff (PDF)

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

The Lancet (British edition), 2008-01, Vol.371 (9609), p.315-321

2008

Volltextzugriff (PDF)

The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion

Supportive care in cancer, 2017-08, Vol.25 (8), p.2399-2403

2017

Volltextzugriff (PDF)

Effect of a public awareness campaign on the incidence of symptomatic objectively confirmed deep vein thrombosis: a controlled study

Journal of thrombosis and haemostasis, 2012-11, Vol.10 (11), p.2287-2290

2012

Volltextzugriff (PDF)

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-07, Vol.386 (9991), p.360-368

2015

Volltextzugriff (PDF)

Changes in Bone Density during Long-Term Administration of Low-Molecular-Weight Heparins or Acenocoumarol for Secondary Prophylaxis of Venous Thromboembolism

Pathophysiology of haemostasis and thrombosis, 2003-01, Vol.33 (2), p.64-67

2003

Volltextzugriff (PDF)

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

BMJ, 2006-02, Vol.332 (7537), p.325-329

International edition, 2006

Volltextzugriff (PDF)

Short term clinical outcome of acute saddle pulmonary embolism

British heart journal, 2003-03, Vol.89 (3), p.335-336

2003

Volltextzugriff (PDF)

Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study

Journal of thrombosis and haemostasis, 2008-08, Vol.6 (8), p.1313-1318

2008

Volltextzugriff (PDF)

Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis

The International journal of biological markers, 2005-01, Vol.20 (1), p.43-49

2005

Volltextzugriff (PDF)

Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis

The International journal of biological markers, 2005, Vol.20 (1), p.43-49

2005

Volltextzugriff (PDF)

Treatment of neoplastic pericardial effusion in lung cancer: comparison of 4 different therapeutic approaches

European heart journal, 2013-08, Vol.34 (suppl 1), p.P3880-P3880

2013

Volltextzugriff (PDF)

Which is the best approach for neoplastic pericardial effusion? A retrospective analysis of 264 cases

European heart journal, 2013-08, Vol.34 (suppl 1), p.P4483-P4483

2013

Volltextzugriff (PDF)

Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer

Lung cancer (Amsterdam, Netherlands), 1997-03, Vol.16 (2), p.215-222

1997

Volltextzugriff (PDF)

Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis

Journal of thrombosis and haemostasis, 2011-01, Vol.9 (1), p.92-99

Equinox Investigators

2011

Volltextzugriff (PDF)

Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism

The American journal of cardiology, 2002-09, Vol.90 (5), p.507-511

2002

Volltextzugriff (PDF)

Artículo especial Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio: Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de las enfermedades del pericardio

2015-12

Volltextzugriff (PDF)

A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation

Journal of thrombosis and haemostasis, 2004-01, Vol.2 (1), p.47-53

2004

Volltextzugriff (PDF)

Intrapericardial administration of cisplatin in treatment of metastatic pericardial involvement in adenocarcinoma of the lung

Monaldi archives for chest disease, 1997-06, Vol.52 (3), p.221

1997

Volltextzugriff (PDF)

Neuron-specific enolase in non-neoplastic lung diseases, a marker of hypoxemia?

The International journal of biological markers, 1998-07, Vol.13 (3), p.150-153

1998

Volltextzugriff (PDF)

Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion

Journal of cancer research and clinical oncology, 1994-07, Vol.120 (7), p.434-436

1994

Volltextzugriff (PDF)

The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis

The International journal of biological markers, 1997-07, Vol.12 (3), p.96-101

1997

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(106)
Berichte
(1)

Sprache

Polnisch
(60)
Englisch
(45)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab-Challenging Recognition and Treatment

Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion

Effect of a public awareness campaign on the incidence of symptomatic objectively confirmed deep vein thrombosis: a controlled study

2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

Changes in Bone Density during Long-Term Administration of Low-Molecular-Weight Heparins or Acenocoumarol for Secondary Prophylaxis of Venous Thromboembolism

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

Short term clinical outcome of acute saddle pulmonary embolism

Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study

Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary

Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis

Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis

Treatment of neoplastic pericardial effusion in lung cancer: comparison of 4 different therapeutic approaches

Which is the best approach for neoplastic pericardial effusion? A retrospective analysis of 264 cases

Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer

Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis

Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism

Artículo especial Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio: Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de las enfermedades del pericardio

A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation

Intrapericardial administration of cisplatin in treatment of metastatic pericardial involvement in adenocarcinoma of the lung

Neuron-specific enolase in non-neoplastic lung diseases, a marker of hypoxemia?

Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion

The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis

Suchergebnisse filtern